"After 6 weeks, comparable reductions of acne lesions, 65% and 68%, were observed in the TauBr and clindamycin groups, respectively. In conclusion, these data support our concept that TauBr can be used as a topical agent in the treatment of acne vulgaris, especially in patients who have already developed antibiotic resistance. "
Marcinkiewicz, Janusz et al. “Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.” European journal of dermatology : EJD vol. 18,4 (2008): 433-9. doi:10.1684/ejd.2008.0460
